586 related articles for article (PubMed ID: 36016444)
1. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
Sakuraba A; Luna A; Micic D
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
[TBL] [Abstract][Full Text] [Related]
2. Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose.
Christophorou E; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Pedersen RM; Justesen US; Johansen NE; Bistrup C; Madsen LW; Johansen IS
Front Immunol; 2023; 14():1270814. PubMed ID: 38090591
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.
Verleye A; Wijtvliet V; Abrams S; Hellemans R; Bougrea R; Massart A; Pipeleers L; Wissing KM; Ariën KK; De Winter BY; Van Damme P; Abramowicz D; Ledeganck KJ
Nephrol Dial Transplant; 2022 Jul; 37(8):1566-1575. PubMed ID: 35544087
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.
Chen X; Luo D; Mei B; Du J; Liu X; Xie H; Liu L; Su S; Mai G
Clin Microbiol Infect; 2023 Apr; 29(4):441-456. PubMed ID: 36509376
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients.
Natori Y; Martin E; Mattiazzi A; Arosemena L; Ortigosa-Goggins M; Shobana S; Roth D; Kupin WL; Burke GW; Ciancio G; Morsi M; Phancao A; Munagala MR; Butrous H; Manickavel S; Sinha N; Sota K; Pallikkuth S; Bini J; Simkins J; Anjan S; Vianna RM; Guerra G
Transpl Int; 2023; 36():10938. PubMed ID: 37091963
[TBL] [Abstract][Full Text] [Related]
6. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
[No Abstract] [Full Text] [Related]
7. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
[TBL] [Abstract][Full Text] [Related]
10. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
Front Immunol; 2022; 13():832501. PubMed ID: 35281023
[TBL] [Abstract][Full Text] [Related]
11. mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
Kwon JH; Tenforde MW; Gaglani M; Talbot HK; Ginde AA; McNeal T; Ghamande S; Douin DJ; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Caspers SD; Exline MC; Botros M; Gong MN; Li A; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Khan A; Hough CL; Busse LW; Duggal A; Wilson JG; Perez C; Chang SY; Mallow C; Rovinski R; Babcock HM; Lauring AS; Felley L; Halasa N; Chappell JD; Grijalva CG; Rice TW; Womack KN; Lindsell CJ; Hart KW; Baughman A; Olson SM; Schrag S; Kobayashi M; Verani JR; Patel MM; Self WH
J Infect Dis; 2022 Sep; 226(5):797-807. PubMed ID: 35385875
[TBL] [Abstract][Full Text] [Related]
12. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
Hoffman TW; Meek B; Rijkers GT; van Kessel DA
Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a Fourth COVID-19 mRNA Vaccine Dose Against the Omicron Variant in Solid Organ Transplant Recipients.
Naylor KL; Knoll GA; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Kim SJ
Transplantation; 2024 Jan; 108(1):294-302. PubMed ID: 38098159
[TBL] [Abstract][Full Text] [Related]
15. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
[TBL] [Abstract][Full Text] [Related]
17. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
[TBL] [Abstract][Full Text] [Related]
18. Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.
Grupper A; Rabinowich L; Ben-Yehoyada M; Katchman E; Baruch R; Freund T; Hagin D; Shlomo SB; Schwartz D; Schwartz IF; Shashar M; Bassat OK; Halperin T; Turner D; Saiag E; Goykhman Y; Shibolet O; Levy S; Houri I; Katchman H
Transplant Proc; 2022; 54(6):1439-1445. PubMed ID: 35346486
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
